How should phenotyping (immunohistochemistry, fluorescence in situ hybridization, next‑generation sequencing) be performed in a newly diagnosed solid tumor, and how do markers such as HER2 (human epidermal growth factor receptor 2), estrogen and progesterone receptors, PD‑L1 (programmed death‑ligand 1), MSI (microsatellite instability)/MMR (mismatch repair) proteins, and TMB (tumor mutational burden) guide treatment decisions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What tests are required for targeted immunotherapy in cancer treatment, including MMR (Mismatch Repair) testing, Tumour Mutational Burden (TMB), Liquid Testing (such as Guardant360), and extended gene panel - genomic testing?
What tests are used to determine the effectiveness of targeted immunotherapy for cancer treatment, including MMR (Mismatch Repair) testing, Tumor Mutational Burden (TMB) testing, and liquid testing such as Guardant testing?
What is the role of Microsatellite Instability (MSI) testing in determining suitability for immunotherapy, specifically with pembrolizumab (pembrolizumab)?
What are the treatment implications for a melanoma tumor with a TERT promoter mutation, microsatellite stability (MSS), and a tumor mutational burden (TMB) of 4.7 mutations per megabase, without alterations in BRAF, NF1, or NRAS?
What is the treatment approach for a patient with a TERT promoter mutation, microsatellite stable (MSS) status, and low tumor mutational burden (TMB)?
In a 54-year-old diabetic male with remote chest trauma presenting with persistent intermittent unilateral chest pain, what imaging and diagnostic studies are indicated and what is the most likely diagnosis?
In an adult with acute stroke symptoms, why is a non‑contrast head CT performed first followed by contrast‑enhanced CT (CT angiography or CT perfusion)?
What does it indicate when a 2‑year‑6‑month‑old child has weight and height below the 3rd percentile but a normal weight‑for‑height?
For an otherwise healthy adult with acute watery diarrhoea, should tinidazole be used, and if so, what are the indications, dosing regimen for Giardia and Entamoeba infections, and contraindications?
What is phenotyping in medicine and how is it applied?
Is it safe to prescribe Syndex‑D Forte (phenylpropanolamine/chlorphenamine/paracetamol) three times daily for two weeks in an adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.